News by Subject Policy & Ethics

Parkinson's disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists in Toronto that puts knowledge sharing and medication affordability ahead of patents and profits.

Lav Varshney, an assistant professor of electrical and computer engineering at the University of Illinois at Urbana-Champaign, will lead a session on 'Blockchain and the Scientific Method' as a part of the American Association for the Advancement of Science (AAAS) annual meeting in Washington D.C., on Feb. 15, 2019.

Investment in research is at an all-time high, yet the rate of scientific breakthroughs isn't setting any records. To resolve this quandary, scientists are turning to artificial intelligence and crowdsourcing for help in identifying a key inspiration for innovation -- the perfect analogy.

Research analysis finds that a moderate level of piracy can have a positive impact on the bottom line for both the manufacturer and the retailer -- and not at the expense of consumers.

According to new research, the terrorist attacks we don't see on the news -- cyberattacks by far-left extremists -- are causing more widespread destruction than we know.

New research by Bocconi University's Paola Cillo and Gaia Rubera with Texas A&M's David Griffith asserts that the reaction of large individual investors to innovation is an important component of stock returns, their reaction to innovation depends on their national culture, and there is a way to segment large individual investors and pitch innovation to them accordingly.

Confusion and ambiguity in how US patients and researchers perceive genetic privacy is uncovered by a study published Oct. 31, 2018 in the open-access journal PLOS ONE by Ellen W. Clayton from Vanderbilt University, USA, and colleagues.